Ullet index:SSP CO.,LTD.:4537

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index SSP CO.,LTD. Go to web site 4537 Medicals TSE December 1, 2000 1969.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

SSP CO.,LTD. mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date December 31, 2009 December 31, 2008 December 31, 2007 March 31, 2007 March 31, 2006
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 57,612
plusdown
57,650
plusdown
62,326
plusdown
62,850
plusdown
66,849
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 1,792
plusup
797
plusdown
1,261
plusup
-888
plusdown
6,200
plus
Operating Cash Flow(OFC)Help 3,055
plusup
1,215
plusdown
4,375
plusup
-5,297
plusdown
3,884
plus
Free Cash Flow(FCF)Help -626
plusup
-9,422
plusdown
5,219
plusup
-7,096
plusdown
16,220
plus
OFC - Net IncomeHelp 68
plusup
68
plusup
67
plusup
65
plusdown
65
plus
Current AssetsHelp -896
plusdown
-864
plusup
-913
plusdown
-887
plusup
-1,043
plus
FCF / Current AssetsHelp 8.99%
plusup
3.84%
plusdown
8.95%
plusup
-12.86%
plusdown
8.03%
plus
Current Assets / Amount of SalesHelp 71.52%
plusup
65.11%
plusdown
128.13%
plusup
80.30%
plusdown
86.98%
plus
Free Cash Revenue RatioHelp -1.32%
plusup
-19.40%
plusdown
13.67%
plusup
-13.83%
plusdown
29.17%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

SSP CO.,LTD.

Company where related level is highHelp

PeptiDream Inc.
Noile-Immune Biotech Inc.
RIBOMIC Inc.
Tsubota Laboratory Incorporated
Cyfuse Biomedical K.K.
Astellas Pharma Inc.
NANO MRNA Co., Ltd.
Kubota Pharmaceutical Holdings Co.,Ltd.
Modalis Therapeutics Corporation
StemRIM Inc.